Name:
Affiliation:
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	None

Public lists managed by

Talks given by

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Epigenetic Regulation of Vascular Ageing and Calcification
• Targeting non-coding RNAs in vascular cell therapy
• Aortic disease in Marfan syndrome: new molecular drivers and therapeutic targets (postponed from Nov 21)
• An optogenetic on/off switch to decipher mechanisms of cardiac remuscularisation
• The Ca2+-gated Cl- channel TMEM16A is a crucial amplifier of capillary pericyte contraction in the normal and ischemic brain.
• Functional genomics of cardiomyopathies
• Sodium channel complexes and cardiac arrhythmia
• Development of virtual heart for the study of cardiac arrhythmias
• Stemcell International Seminar - Prof. Paul Riley. BHF Oxbridge Centre for Regenerative Medicine
• A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
• Cardiovasculal MR - New Insights in Heart Diseases -today and in future
• Novel Mitochondrial Mechanisms for Cardiometabolic Disease
• Taking control of innate immunity with nanobiologics
• Detecting the early spread of SARS-Cov-2 in humans by phylogenetic network analysis
• Hydroxychloroquine in COVID-19 treatment: cardiac safety
• CANCELLED Transcriptional control of heart development and regeneration CANCELLED
• TBC A novel mechanosensor in the endothelium that regulates the site-specific distribution of atherosclerosis
• CANCELLED Translational approaches with human induced pluripotent stem cell-derived cardiomyocytes CANCELLED
• Using next generation sequencing to delineate novel chamber-specific molecular mechanisms in different aetiologies of human heart failure
• Gene Therapy in Duchenne Cardiomyopathy
• Purinergic control of inflammation and cell death
• Cardio-oncology - A compatible Marriage of Convenience?
• Texture Analysis and Machine Learning for the Prediction of Cerebrovascular Events.
• From first in man to advanced preclinical trials and then back: bridging the gap in cardiovascular translation
• Generating left ventricle cardiomyocytes from human pluripotent stem cells using mouse instructions
• The gut microbiota in arterial thrombosis
• Cardiac imaging: the hero and the villain in the story of regenerative medicine
• Multimodal Imaging of Carotid Atherosclerosis and the Neurovascular Interface in Cerebrovascular Disease
• Multi-tasking for MR Image Enhancement:From Acceleration to Motion Correction
• Bioengineering approach to atherosclerosis and aneurysm rupture and clinical implications
• Adapting to extrauterine life and beyond: AMPK coordinates breathing and oxygen supply
• Phenotyping iPS-CM's with light
• Macrophages in many guises in atherosclerosis progression and regression
• Platelets: biogenesis, ballooning and biorepair
• Neutrophils in vascular inflammation – from physiology to intervention
• Mural cells in vascular disease
• Quantification of arterial pulse wave morphology:new data from an old signal
• It takes two to tango:platelet collagen receptor GPVI-dimer in thrombosis and clinical implications
• Exercise intolerance in PAH: more than just the lungs!
• TGFβ signalling is a novel regulator of haemogenic endothelium programming and haematopoietic stem cell emergence
• Insight into the molecular mechanism of extracellular matrix calcification in the vasculature from NMR spectroscopy and electron microscopy
• Zooming in on small vessel disease and dementia with 7T MRI
• Smooth muscle specific alternative splicing: super-enhancers point the way
• A role for the sodium channel beta 3 subunit in clustering the heart-specific sodium channel Nav1.5: Structural and functional implications.
• Exosomal KLF2-induced microRNAs: implications for treatment of pulmonary hypertension
• Why does cardiac function deteriorate in heart failure and how does phosphodiesterase 5 inhibition help?
• Prescribing step counts in type 2 diabetes and hypertension:Results of the Step Monitoring to improve ARTERial health trial
• MOVED TO 28 JUNE 2018 It takes two to tango:platelet collagen receptor GPVI-dimer in thrombosis and clinical implications
• Remote ischemic conditioning- signal transduction and clinical translation
• What is the translational potential of elucidating Wnt/b-catenin signalling in smooth muscle?
• Cardiovascular risk prediction:current status and next steps
• The role of myosin VI in connexin 43 gap junction accretion
• An enhancer-centric approach to understanding gene regulation within the heterogeneous vasculature:Novel roles for SOXF,SMAD and MEF2 factors
• Microtubule Modulation of Myocyte Mechanics
• The RNAissance:Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease
• Molecular mechanisms of cardiomyopathies in patients with severe non-ischemic heart failure
• Role of Tissue Factor in Hemostasis and Thrombosis
• Epigenetic and genome architecture dynamics from ES cells to terminal cardiac and neuronal differentiation
• Genetic Prediction of Cardiovascular Disease
• HERG potassium channels: Friend or Foe